XOVR Among Its Peers
End-of-day Nov 19, 2026 · 0 ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.4% | −5.1% | −11.7% | −6.5% | −5.5% | −2.8% | — | — | — | +34.6% |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$68 of every $1,000 in XOVR is Nvidia
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —SPV Exposure to SpaceX LP | — | 16.40% | $1,640.45 | 0 | $207.1M |
| 2 | NVDANvidia | Technology | 6.82% | $682.18 | 570K | $86.1M |
| 3 | GOOGLAlphabet | Communication Services | 5.29% | $528.99 | 236K | $66.8M |
| 4 | METAMETA Platforms | Communication Services | 4.52% | $452.03 | 93K | $57.1M |
| 5 | UIUbiquiti | Technology | 4.48% | $447.55 | 83K | $56.5M |
| 6 | CARTMaplebear | Technology | 4.42% | $441.79 | 951K | $55.8M |
| 7 | —Kalshi | — | 4.21% | $420.61 | 46K | $53.1M |
| 8 | TOSTToast | Technology | 3.84% | $383.68 | 1.4M | $48.4M |
| 9 | SPCXSpace Exploration Technologies | Industrials | 3.83% | $382.73 | 337K | $48.3M |
| 10 | APPAppLovin | Technology | 3.16% | $316.41 | 102K | $39.9M |
| 11 | GMEDGlobus Medical | Healthcare | 2.97% | $296.52 | 531K | $37.4M |
| 12 | NBIXNeurocrine Biosciences | Healthcare | 2.74% | $273.82 | 212K | $34.6M |
| 13 | EXELExelixis | Healthcare | 2.61% | $261.01 | 482K | $32.9M |
| 14 | VEEVVeeva Systems | Technology | 2.53% | $253.02 | 115K | $31.9M |
| 15 | ABNBAirbnb | Consumer Cyclical | 2.50% | $250.28 | 175K | $31.6M |
XOVR has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | NVDA | Nvidia | 6.82% |
| 2 | GOOGL | Alphabet | 5.29% |
| 3 | META | META Platforms | 4.52% |
| 4 | UI | Ubiquiti | 4.48% |
| 5 | CART | Maplebear | 4.42% |
| 6 | TOST | Toast | 3.84% |
| 7 | SPCX | Space Exploration Technologies | 3.83% |
| 8 | APP | AppLovin | 3.16% |
| 9 | GMED | Globus Medical | 2.97% |
| 10 | NBIX | Neurocrine Biosciences | 2.74% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| XOVR | −0.35 | −0.50 | 26.1% | −20.4% | 1.44 | $75 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 21, 2021 | Dec 28, 2021 | $8.73 |
| Dec 21, 2020 | Dec 23, 2020 | $1.65 |
| Dec 19, 2019 | Dec 23, 2019 | $0.0144 |
| Dec 18, 2018 | Dec 20, 2018 | $0.52 |
| Dec 22, 2017 | Dec 28, 2017 | $0.0127 |